Accenture Backs Turbine’s AI-Powered Platform to Accelerate Drug Discovery

May 16, 2024


Turbine’s core technology, the Simulated Cell platform, leverages machine learning to decipher human cell decision-making processes. By intricately modeling molecular interactions within and around cells, the platform facilitates virtual experiments on a massive scale, exceeding the capabilities of the physical world. This unveils disease mechanisms and treatment response patterns with unprecedented detail.

Unlocking Hidden Gems: More Effective Treatments

Leading pharmaceutical companies are collaborating with Turbine to validate its platform for several key applications:

Read More on HitConsultant